By Laurie Watanabe | May 29, 2019Zolgensma Manufacturer: FDA Approval Is “Just the Beginning” of SMA Treatment The one-time dose treatment for children under age 2 was given the green light last week.
By Laurie Watanabe | December 10, 2018New Gene Therapy Drug for SMA Gets FDA Priority Review AVXS-101 showed promising results in clinical trial with infants who have spinal muscular atrophy type 1.
By Laurie Watanabe | September 6, 2018Researchers: New Subtype of Multiple Sclerosis Does Not Damage Brain’s White Matter Latest discovery changes previous understanding of how MS progresses and alters neurological system.
By Laurie Watanabe | December 11, 2017Cure SMA: Children on Nusinersen More Likely to Achieve Milestones A new study examines the impact of the drug treatment on Type 1 infants.
By Laurie Watanabe | September 20, 2017New Duke Research to Study Optimal Repositioning Times Study aims to provide updated guidelines on repositioning patients to prevent pressure injuries.
By Laurie Watanabe | June 21, 2017Researchers: Measuring Neurofilaments Could Speed ALS Diagnosis Belgian and German study suggests a reliable and faster way to determine if a patient has amyotrophic lateral sclerosis.
By Laurie Watanabe | June 14, 2017Study: Smoking Worsens SCI Pain New Purdue University study could lead to new ways to treat neuropathic pain in spinal cord injuries.
By Laurie Watanabe | May 15, 2017AAP: Kids with Neurodevelopmental Conditions Should Be Screened for Vision Problems Vision problems can further impact the development of a young child with disabilities.
By Laurie Watanabe | May 15, 2017Research: Dogs Can Raise Activity Levels for Kids with Disabilities Oregon State study finds a wide range of physical and social benefits.
By Laurie Watanabe | March 17, 2017Maternal Obesity Tied to Cerebral Palsy in Newborns New study examined more than a million births in Sweden.
